One hundred of the fibers prepared above were cultured on a plate coated with Matrigel matrix (Corning Incorporated, Corning, NY, USA) with 500 μl standard medium (DMEM containing 25 mM glucose supplemented with 20% fetal bovine serum (Thermo Fisher Scientific), 2% chick embryo extract (United States Biological, Salem, MA, USA), and 1% penicillin–streptomycin (PS, 10,000 U/ml, Thermo Fisher Scientific) at 37 °C under 5% CO2 for 24 h. A mixture of two Pfkfb3 siRNA duplexes (siPfkfb3, 200 nM, SASI_Mm01_00034119 and SASI_Mm01_00034121 (Sigma-Aldrich)) or two Pdk4 siRNA duplexes (siPdk4, 100 nM, SASI_Mm01_00053023 and SASI_Mm01_00053024 (Sigma-Aldrich)) were transfected into the fibers using Lipofectamine RNAiMAX (Thermo Fisher Scientific) for 6, 9, 12, or 24 h in standard medium without PS. Stealth RNAiTM siRNA Negative Control, Med GC (Thermo Fisher Scientific) was used as a negative control. Transfection was performed according to the manufacturer’s protocol and the procedure described by Huttner et al. 82. RNAs were prepared from the fibers and then subjected to qRT-PCR of Pfkfb3 and Pdk4.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.